Long COVID-19: A Primer for Cardiovascular Health Professionals, on Behalf of the CCS Rapid Response Team

It is now widely recognized that COVID-19 illness can be associated with significant intermediate and potentially longer-term physical limitations. The term, “long COVID-19” is used to define any patient with persistent symptoms after acute COVID-19 infection (ie, after 4 weeks). It is postulated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Paterson, Ian, Ramanathan, Krishnan, Aurora, Rakesh, Bewick, David, Chow, Chi-Ming, Clarke, Brian, Cowan, Simone, Ducharme, Anique, Gin, Kenneth, Graham, Michelle, Gupta, Anil, Jassal, Davinder S., Kazmi, Mustapha, Krahn, Andrew, Lamarche, Yoan, Marelli, Ariane, Roifman, Idan, Ruel, Marc, Singh, Gurmeet, Sterns, Larry, Turgeon, Ricky, Virani, Sean, Wong, Kenny K., Zieroth, Shelley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Canadian Cardiovascular Society. Published by Elsevier Inc. 2021
Materias:
Training/Practice Contemporary Issues in Cardiology Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180343/
https://www.ncbi.nlm.nih.gov/pubmed/34090980
http://dx.doi.org/10.1016/j.cjca.2021.05.011
Descripción
Sumario:It is now widely recognized that COVID-19 illness can be associated with significant intermediate and potentially longer-term physical limitations. The term, “long COVID-19” is used to define any patient with persistent symptoms after acute COVID-19 infection (ie, after 4 weeks). It is postulated that cardiac injury might be linked to symptoms that persist after resolution of acute infection, as part of this syndrome. The Canadian Cardiovascular Society Rapid Response Team has generated this document to provide guidance to health care providers on the optimal management of patients with suspected cardiac complications of long COVID-19.

Ejemplares similares